here is a plethora of information - digg in and you will be shocked...
plethora link-
http://www.ncbi.nlm.nih.gov/sites/entrez

just in case you can't find the door -here are the case studies

2: Related Articles, LinksHalvorsen Ø, Tysnes OB.

[Dementia in Parkinson's disease]
Tidsskr Nor Laegeforen. 2007 Oct 4;127(19):2517-20. Review. Norwegian.
PMID: 17925819 [PubMed - indexed for MEDLINE]3: Related Articles, LinksHammoud DA, Hoffman JM, Pomper MG.

Molecular neuroimaging: from conventional to emerging techniques.
Radiology. 2007 Oct;245(1):21-42. Review.
PMID: 17885179 [PubMed - indexed for MEDLINE]4: Related Articles, LinksRozzini L, Chilovi BV, Bertoletti E, Conti M, Delrio I, Trabucchi M, Padovani A.

Mild parkinsonian signs and psycho-behavioral symptoms in subjects with mild cognitive impairment.
Int Psychogeriatr. 2007 Sep 17;:1-10 [Epub ahead of print]
PMID: 17868495 [PubMed - as supplied by publisher]5: Related Articles, LinksRodriguez RL, Fernandez HH, Haq I, Okun MS.

Pearls in patient selection for deep brain stimulation.
Neurologist. 2007 Sep;13(5):253-60. Review.
PMID: 17848865 [PubMed - indexed for MEDLINE]6: Related Articles, LinksZgaljardic DJ, Borod JC, Foldi NS, Rocco M, Mattis PJ, Gordon MF, Feigin AS, Eidelberg D.

Relationship between self-reported apathy and executive dysfunction in nondemented patients with Parkinson disease.
Cogn Behav Neurol. 2007 Sep;20(3):184-92.
PMID: 17846518 [PubMed - in process]7: Related Articles, LinksHerrmann W, Lorenzl S, Obeid R.

[Review of the role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric disorders--current evidence and preliminary recommendations]
Fortschr Neurol Psychiatr. 2007 Sep;75(9):515-27. Review. German.
PMID: 17729191 [PubMed - indexed for MEDLINE]8: Related Articles, LinksEmre M, Cummings JL, Lane RM.

Rivastigmine in dementia associated with Parkinson's disease and Alzheimer's disease: similarities and differences.
J Alzheimers Dis. 2007 Jul;11(4):509-19. Review.
PMID: 17656830 [PubMed - indexed for MEDLINE]9: Related Articles, LinksBoecker H, Ceballos-Baumann AO, Volk D, Conrad B, Forstl H, Haussermann P.

Metabolic alterations in patients with Parkinson disease and visual hallucinations.
Arch Neurol. 2007 Jul;64(7):984-8.
PMID: 17620488 [PubMed - indexed for MEDLINE]10: Related Articles, LinksWesnes K.

Rivastigmine tartrate with a focus on dementia associated with Parkinson's disease.
Drugs Today (Barc). 2007 Jun;43(6):349-59. Review.
PMID: 17612707 [PubMed - indexed for MEDLINE]11: Related Articles, LinksRandhawa S, Walterfang M, Miller K, Scholes A, Mocellin R, Velakoulis D.

The development and validation of a carer questionnaire to assess cognitive function in neuropsychiatric patients.
J Psychosom Res. 2007 Jul;63(1):93-8.
PMID: 17586342 [PubMed - indexed for MEDLINE]12: Related Articles, LinksWeintraub D, Stern MB.

Intervening in the neuropsychiatric features of Parkinson's disease.
Expert Rev Neurother. 2007 Jun;7(6):699-710. Review.
PMID: 17563252 [PubMed - indexed for MEDLINE]13: Related Articles, LinksDoi N, Sameshima T, Suwa H, Mera H, Nagao T, Yokochi M, Nakamura M, Isse K.

[Electroconvulsive therapy for neurological disorders]
Brain Nerve. 2007 Apr;59(4):313-20. Review. Japanese.
PMID: 17447517 [PubMed - indexed for MEDLINE]14: Related Articles, LinksHalkias IA, Haq I, Huang Z, Fernandez HH.

When should levodopa therapy be initiated in patients with Parkinson's disease?
Drugs Aging. 2007;24(4):261-73. Review.
PMID: 17432922 [PubMed - indexed for MEDLINE]15: Related Articles, LinksRossi L, Foffani G, Marceglia S, Bracchi F, Barbieri S, Priori A.

An electronic device for artefact suppression in human local field potential recordings during deep brain stimulation.
J Neural Eng. 2007 Jun;4(2):96-106. Epub 2007 Mar 13.
PMID: 17409484 [PubMed - indexed for MEDLINE]16: Related Articles, LinksCastaño B, Mateo D, Giménez-Roldán S.

[Shifting to subcutaneous infusion of apomorphine in advanced Parkinson's disease patients on an out-patient basis: experience and recommendations]
Neurologia. 2007 Apr;22(3):133-7. Spanish.
PMID: 17364250 [PubMed - indexed for MEDLINE]17: Related Articles, LinksCohen OS, Vakil E, Tanne D, Nitsan Z, Schwartz R, Hassin-Baer S.

Educational level as a modulator of cognitive performance and neuropsychyatric features in Parkinson disease.
Cogn Behav Neurol. 2007 Mar;20(1):68-72.
PMID: 17356347 [PubMed - indexed for MEDLINE]18: Related Articles, LinksFigved N, Myhr KM, Larsen JP, Aarsland D.

Caregiver burden in multiple sclerosis: the impact of neuropsychiatric symptoms.
J Neurol Neurosurg Psychiatry. 2007 Oct;78(10):1097-102. Epub 2007 Jan 19.
PMID: 17237144 [PubMed - indexed for MEDLINE]19: Related Articles, LinksFerreri F, Agbokou C, Gauthier S.

Recognition and management of neuropsychiatric complications in Parkinson's disease.
CMAJ. 2006 Dec 5;175(12):1545-52. Review.
PMID: 17146092 [PubMed - indexed for MEDLINE]20: Related Articles, LinksGalvin JE.

Cognitive change in Parkinson disease.
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):302-10. Review.
PMID: 17132978 [PubMed - indexed for MEDLINE

Theor Biol Med Model. 2007; 4: 10. Published online 2007 February 26. doi: 10.1186/1742-4682-4-10.
Copyright © 2007 Wallace et al; licensee BioMed Central Ltd.
Collective consciousness and its pathologies: Understanding the failure of AIDS control and treatment in the United States
Rodrick M Wallace,1 Mindy T Fullilove,1 Robert E Fullilove,2 and Deborah N Wallace3
1The New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY, 10032, USA
2Joseph L. Mailman School of Public Health, Columbia University, 722 W. 168 St., New York, NY, 10032, USA
3Consumers Union, 101 Truman Ave., Yonkers, NY, 10703, USA
Corresponding author.
Rodrick M Wallace: wallace@pi.cpmc.columbia.edu; Mindy T Fullilove: mf29@columbia.edu; Robert E Fullilove: ref5@columbia.edu; Deborah N Wallace: wallde@consumer.org
Received December 12, 2006; Accepted February 26, 2007.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.